Prot #TNG908-C101: A Phase 1/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Anti-Tumor Activity of TNG908 in Patients with MTAP-Deleted Advanced or Metastatic Solid Tumors

Project: Research project

Project Details

StatusActive
Effective start/end date2/21/24 → 2/21/27

Funding

  • PPD Investigator Services, LLC (Prot #TNG908-C101 // Prot #TNG908-C101)
  • Tango Therapeutics, Inc. (Prot #TNG908-C101 // Prot #TNG908-C101)